MedPath

On target management for secondary hyperparathyroidism by two calcimimetics (HP2C study)

Not Applicable
Conditions
Chronic kidney disease
Registration Number
JPRN-UMIN000029000
Lead Sponsor
Hyogo College of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with sever heart failure (>NYHA III),liver dysfunction, respiratory failure, and malignant tumor.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath